Firm

Sumin Lai of Saint Island International Patent & Law Offices outlines how the decisions offer valuable insights into inventive step assessment in Taiwanese patent disputes

Kerstin Wolff and Tobias Matschke of Maiwald Intellectual Property examine a landmark Unified Patent Court decision on second medical use claims and compare it with Germany’s established approach to ‘skinny label’ products

Herman Blignaut of Spoor & Fisher South Africa addresses whether the act extends to intellectual property rights and reassures brand owners that constitutional protection remains intact

Jakob Pade Frederiksen of Inspicos analyses a ruling confirming that patent claims must be interpreted with reference to the description and drawings

Ranjan Narula and Anita Rawat of RNA, Technology and IP Attorneys address the main questions concerning India’s regulation of greenwashing across advertising, financial products, and the food sector

As an AstraZeneca patent survives a tenth invalidation challenge in China, Jianhui Li of Wanhuida Intellectual Property considers the implications for generic drug makers and the pharmaceutical industry